GABA-A receptor agonists

Preferred Label : GABA-A receptor agonists;

MeSH definition : Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS.;

MeSH synonym : agonists, GABA-A receptor; receptor agonists, GABA-A; GABA-A receptor agonist; agonist, GABA-A receptor; GABA A receptor agonist; receptor agonist, GABA-A; GABA-A agonists; agonists, GABA-A; GABA A agonists; GABA A receptor agonists;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D058785;

UMLS CUI

C2936799;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Gamma-aminobutyric acid A receptor agonist (disposition) [SNOMED CT concept]
- Gamma-aminobutyric acid receptor agonist (disposition) [SNOMED CT concept]
Indexing information
- 8-ethynyl-6-(2'-pyridine)-4H-2,5,10b-triazabenzo(e)azulene-3-carboxylic acid ethyl ester [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, GABA-A [MeSH Descriptor]
Record concept(s)
- GABA-A receptor agonists [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one [MeSH Supplementary Concept]
- 2-methoxy-3,8,9-trihydroxy coumestan [MeSH Supplementary Concept]
- 3'-(5-(1-hydroxy-1-methylethyl)benzoimidazol-1-yl)biphenyl-2-carbonitrile [MeSH Supplementary Concept]
- 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl) 7-bromo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5.alpha)-benzodiazepine [MeSH Supplementary Concept]
- 3-amino-2-fluoropropylsulfinic acid [MeSH Supplementary Concept]
- 3-phenyl-6-(2-pyridyl)methoxy-7,8,9,10-tetrahydro(7,10-ethano)-1,2,4-triazolo(3,4-a)phthalazine [MeSH Supplementary Concept]
- 6,3'-dibromoflavone [MeSH Supplementary Concept]
- 6-nitro-3'-bromoflavone [MeSH Supplementary Concept]
- 7-chloro-5((cis-3,5-dimethylpiperazine)carbonyl)imidazo(1,5a)quinoline-3-carboxylate [MeSH Supplementary Concept]
- 7-cyclobutyl-6-(2-methyl-2H-1,2,4-triazol-3-ylmethoxy)-3-phenyl-1,2,4-triazolo(4,3-b)pyridazine [MeSH Supplementary Concept]
- 9-chloro-2-phenyl-(1,2,3)triazolo(1,2-a)(1,2,4)benzotriazin-1,5(6H)-dione [MeSH Supplementary Concept]
- 9-chloro-7-(2-chlorophenyl)-5H-pyrimido(5,4-d)(2)benzazepine [MeSH Supplementary Concept]
- Clobazam [MeSH Descriptor]
- L 838,417 [MeSH Supplementary Concept]
- N,N-dimethyl-(2-(4-methylphenyl)-5-methylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide [MeSH Supplementary Concept]
- N-(3-fluoro-4-(2-(propylamino)ethoxy)phenyl)-4,5,6,7-tetrahydro-4-oxo-1H-indole-3-carboxamide [MeSH Supplementary Concept]
- N-(p-methylbenzyl)-5-nitroindol-3-ylglyoxylamide [MeSH Supplementary Concept]
- NNC 14-0185 [MeSH Supplementary Concept]
- NNC 14-0189 [MeSH Supplementary Concept]
- Zolpidem [MeSH Descriptor]
- abp-700 [MeSH Supplementary Concept]
- deschloroetizolam [MeSH Supplementary Concept]
- lesogaberan [MeSH Supplementary Concept]
- muscimol [MeSH Descriptor]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients